Company* (Country; Symbol) Company Type/Product Area Terms/Details (Date)
Kylin Therapeutics Inc.* Fort Dodge Animal Health (division of Wyeth) Collaboration to develop RNAi therapeutics for the treatment of cancer Kylin will use its RNA nanoparticle technology called "pRNA" in the effort; Fort Dodge gets an exclusive license to the pRNA/RNAi therapeutic compounds for the treatment of cancers in companion animals; Kylin retains rights to the therapies for human use; Kylin is entitled to research funding along with potential mile-stone and royalty payments (9/20)
Notes:

* Private companies are indicated with an asterisk.

Unless otherwise noted, the trading symbols listed for public companies are on the Nasdaq market.